The G-protein coupled receptors -or GPCRs -comprise simultaneously one of the largest and one of the most multi-functional protein families known to modern-day molecular bioscience. From a drug discovery and pharmaceutical industry perspective, the GPCRs constitute one of the most commercially and economically important groups of proteins known. The GPCRs undertake numerous vital metabolic functions and interact with a hugely diverse range of small and large ligands. Many different methodologies have been developed to efficiently and accurately classify the GPCRs. These range from motif-based techniques to machine learning as well as a variety of alignment-free techniques based on the physiochemical properties of sequences. We review here the available methodologies for the classification of GPCRs. Part of this work focuses on how we have tried to build the intrinsically hierarchical nature of sequence relations, implicit within the family, into an adaptive approach to classification. Importantly, we also allude to some of the key innate problems in developing an effective approach to classifying the GPCRs: the lack of sequence similarity between the six classes that comprise the GPCR family and the low sequence similarity to other family members evinced by many newly revealed members of the family.
Introduction
The speed at which new protein sequences are discovered seems to constantly accelerate as new technology, such as third-generation instrumental sequencing, comes on-stream. However, many of these newly-sequenced proteins show strong, or at least overt, similarity to existing sequences: in terms of novelty, the proportion of new yet redundant sequences is also constantly increasing. This may indicate that we are close to defining a final complement of biological sequences available within nature. This virtual "global proteome" is estimated at close to five million sequences [1] . In light of this, and the bewildering productivity of metagenomics [2] , the efficient analysis of protein sequences to determine structure and function has become an imperative goal of genomics. Bioinformatics, the application of knowledge-driven science to biological macromolecules and the complex systems that arise from their interactions, can collate and capitalise on this wealth of information by developing efficient and incisive algorithms for its analysis.
The coming step change apparent with biomedicine presents us with a confounding embarrassment of riches; a term which incidentally entered English as long ago as 1738 in John Ozell's translation of a French play, L'Embarras des richesses (1726).
The embarrassment of riches set to become ever richer in complexity and detail yet our inability to deal with it is set to become ever more embarrassing. The English language remains enthral to the common parlance of the past. Even today, in the globalised, multi-cultural twenty-first century, much of our idiomatic speech is submerged by the nautical vocabulary of the Eighteenth century or corralled by the high phrasing of William Tyndale's 1528 bible. In much the same way, our ways of thinking and of acting and of being can remain wedded to the past, hampered and constrained by unnecessary conservatism and caution, as seen in the way that so many cling to outmoded ways of tackling pressing and exigent issues. We need new and innovative approaches to functional genomics as much as we need them in business, politics, and diverse other areas of human activity. Fully rather than partially engaging with the potential of computer science is one such innovation. Experimentalists must allow themselves to be directed by data-hungry informatics analysis, abandoning their rigid instance on necessarily-restrictive experiment-first, hypothesis-driven research in favour of an approach that embraces the full potential of research that is driven instead by the informatics-led discovery and analysis of data [3] .
The very large amount of data concerning protein function currently available is of incalculable valuable, since within it is the potential to understand better the nature of disease, and through that understanding to enact better treatment, instantiated by the design of more effective drugs, therapies, and vaccines. However, to properly capitalise on this rare potential, we need to use intelligent data analysis. This has been given the catchy epithet: "data mining" (DM), since it involves "mining", that is, identifying and analysing, raw data; transforming it first into information, then useful knowledge, and eventually, it may be hoped, into true understanding [4] .
Biomedical discovery can often hinge upon effective computational sequence analysis revealing important and unexpected functional relationships between members of protein families. DM is a discipline within informatics that seeks to extract patterns from raw data that are useful, non-trivial, and previously unknown [5] [6]. When performing the DM task of classification, algorithms are exposed to input data, identifying therein patterns and regularities which are subsequently used to make predictions. In terms of machine learning terminology, the task of classification is a form of supervised learning where the patterns discovered by DM can be used to infer a class (or classification) of previously unseen or unclassified data; in this way the class (or function) of a protein can be predicted by these previously discovered patterns. Automated function prediction through classification algorithms is now a vital if underappreciated component of biological discovery, since new sequences are currently discovered at such a prodigious rate that classification is a task far beyond anything that manual labelling can achieve. Soon, new genomes may be delivered on a daily basis. The concomitant interpretation-gap will become huge beyond measure and, without automation, making sense of this glut of data will be impossible.
The potential confusion inherent within such a scenario has long been foreshadowed by our experience of one particular protein family: the G-protein coupled receptors or GPCRs. The GPCRs comprise a large and varied multi-gene super-family which consists of integral membrane proteins involved in seemingly innumerable physiological functions [7] [8] . GPCRs are, for example, responsible for turning diverse extracellular and endogenous signals into a limited number of intracellular responses. A heterogeneous collection of molecules act as GPCR ligands:
these include light, in the form of photons; ions; hormones; neurotransmitters; peptides; and proteins. Since GPCRs are implicit in physiological processes as diverse as neurotransmission, cellular metabolism, secretion, inflammatory responses, and cellular differentiation [9] , they have become a consistent target for the development of medicines: roughly 50% of all marketed drugs target a GPCR [10] . Most anti-GPCR therapies have been derived through the somewhat haphazard processes innate to medicinal chemistry; driven, as it certainly was in times past when GPCR structures were not available, by the whims and caprices of synthetic chemistry rather than the focussed, rationality of structure-based design. Now, of course, through both sequence analysis and the determination of crystal structures, there is much that initial in silico approaches can tell us about newly determined GPCR sequences, including forecasts of its potential function. Despite the diversity of the superfamily, there are many commonalities among GPCRs. Every member of the GPCR superfamily contains seven highly conserved transmembrane segments (of 25-35 consecutive residues), each displaying a high degree of hydrophobicity. Rather than forming a perfect circle or regular ellipse, the seven membrane-crossing α-helical segments (TM1-7) form a flattened two-layer structure known as the transmembrane bundle, which is thought to be common to all GPCRs [11] .
Compared to many apparently similar sets of proteins, the GPCRs exhibit a far greater conservation of structure than of sequence. In this review, we seek to place this assertion into context and explore some of its implications. The proteome of a cell is considerably larger, more complex, and certainly more interesting than its genome.
Some estimates place the number of proteins encoded by the human genome 2-3 orders of magnitude higher than the number of genes. Mechanisms, including splice variants, inteins, post-translational modifications, cleavage of precursors, and other types of proteolytic activation, magnify the number of protein products by an order of magnitude [12] .
Moreover, the proteome is more dynamic than the genome, showing greater differences between individual human patients, and exhibiting more profound differences with cell type, functional status, and disease state. Identifying, cataloguing and characterising an individual's proteome and its complement of GPCRs, will doubtless prove more challenging than did annotating the genome. Analysing proteomes can only be addressed, and addressed convincingly, by coupling the experimental to the computational. Here we outline various approaches that have been used to develop GPCR classification algorithms and attempt to highlight the strengths and weaknesses of the various approaches. By reviewing the various computational techniques used to classify and categorise the GPCRs, we will explore how the severe computational challenge presented by the complex hierarchical classification of the GPCRs has and will be met. Approaches such as those we describe will have important applications not only in discovering and characterising novel protein sequences but also in better understanding the interrelatedness apparent between known members of the GPCR superfamily.
Brief Overview of Nomenclature, Classification, and Repertoires
General, immanent difficulties in producing a comprehensive classification system for the protein super-families have existed for some time; as long perhaps as sufficient numbers of protein sequences to warrant such an analysis have been available [13] .
Since they are so numerous, and the interrelationships within the group so complex, the GPCRs have proved especially contentious. Evolutionary relationships between different GPCR groups are not certain; some receptors may have arisen through convergent evolution to adopt a particular structural scaffold, and may not even be homologous.
Even selecting an appropriate nomenclature has provoked controversy. The term "family" has long been used to describe groupings with the GPCRs. The definition of family does not rely solely on the possession of sequence similarity, but also embraces a larger set of functional, structural, and evolutionary features. In this context, and when viewed rigorously, the term "superfamily" can seem ambivalent and confusing.
Unfortunately, and despite such difficulties, there is not -and possibly there never will be -any overarching term or collective noun able to include and subsume all GPCR sequences. Many have been suggested. Umma, for example, is used as a collective term encompassing the community, the totality of all Muslims, irrespective of all other allegiances. Thus, umma can serve as term able to sit above all other definitions of familial propinquity; it can imply relatedness in some not wholly explicit sense. Another such expression is "clan" [14] : it uses the idea of kinship leniently, recognizing both convergent and divergent evolution. Because of its pervasive usage, we retain here the terms: family and superfamily. They are useful, if flawed, catch-all expressions and can encompass both homologous and nonhomologous protein families.
One of the first GPCR superfamily classification systems was introduced by Kolakowski for the now defunct GCRDb database [15] , and further developed by Vriend et al. for the GPCRDB database [16] [17] [18] . GPCRDB divides the superfamily into six classes. The first of which is Class A, the so-called Rhodopsin-like GPCRs, accounting for over 80% of family members across species. There are around 300 human non-olfactory Class A receptors mostly binding peptides, biogenic amines or lipids [19] .
Peptide-binding receptors play important roles in mediating neurotransmitters, hormones and paracrine signals. Receptors which bind to biogenic amines, such as norepinephrine, dopamine, and serotonin, constitute a set of major drug targets, since pathological conditions -schizophrenia, Parkinson's disease, and depression amongst others -are excellent examples of where unbalanced endogenous amine levels lead to altered brain function. Likewise, diligent, sedulous, and assiduous efforts over two decades have led to a remarkable transformation in our knowledge of the structural basis of ligand-mediated functioning of the rhodopsin-like GPCRs: the structure of bovine rhodopsin published in 2000 has been followed more recently by those of ligand-bound avian and human β 1 -and β 2 -adrenoceptors, and the human A 2A adenosine receptor, which were determined in an inactive, ligand-bound conformation [20] [21] [22] [23] [24] .
The second class is Class B or Secretin-like GPCRs; as a group they have only weak similarity at the sequence level to Class A receptors, despite a presumed similarity of more significant proportions at the structural and functional level [25] .
The group is also rather smaller, with only 15 members, which bind large endogenous peptides such as: glucagon; the incretins -glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP); vasoactive intestinal peptide (VIP), secretin and calcitonin; parathyroid hormone (PTH); corticotropin-releasing factor (CRF); growth-hormone releasing factor (GRF); and pituitary adenylate cyclase activating polypeptide (PACAP) [26] . The secretin-like receptors have a large Nterminal extracellular domain of 100 to 160 residues, which plays a vital part in binding ligands. No complete class B structure has been determined, however; nonetheless, a structure corresponding to the N-terminal ligand binding domain has been solved for 6 different receptor subtypes, which, when combined with biophysical data gives real insight into the structural basis of ligand binding [27] [28] [29] .
The third class is Class C and comprises the Metabotropic glutamate-like receptors (mGluRs). These excitatory neurotransmitter receptors are activated via an indirect metabotropic process [30] . In humans, mGluRs are found principally within pre-and postsynaptic neurons in the hippocampus, cerebellum and the cerebral cortex, as well as other regions of the brain and in the periphery [31] .
The fourth class is Class D, which contains about 20 distinct receptors, is comprised of highly-diverged receptors for peptide pheromones [32] The fifth class of GPCRs is Class E, comprising cAMP receptors from the protozoan amoeba Dictyostelium discoideum, which form part of several chemotactic signalling systems [30] . Compared to other lower eukaryotes with sequenced genomes, Dictyostelium has over 55 GPCRs: including four receptors for extracellular cAMP [34] [35] . cAR1, the best characterized cAMP receptor, is essential for the starvation-induced aggregation of up to 10 5 Dictyostelium amoebae and subsequent development. cAR1 mediates cellular chemotaxis along cAMP gradients and also induces critical aggregation-stage genes, including cAR1 and its G-protein partner
Gα2. In addition to class D and E, other groups of GPCRs are only found exclusively outside the subphylum vertebrata, such as the large family of nematode chemosensory receptors [36] .
Finally, the sixth class is Class F, which contains Frizzled/smoothened receptors from Drosophila, which are necessary for Wnt binding and the mediation of hedgehog signalling respectively [37] . This recently identified a group of 7 TM receptors are considered the most highly diverged, especially with respect to rhodopsin [38] .
An alternative, and potentially superior, sequence-based classification system has been proposed for the GPCR family [39] [40] . The GRAFS classification system was developed using phylogenetic analysis [41] . GRAFS divides the GPCR superfamily into the Glutamates, Rhodopsins, Adhesions, Frizzled/Taste 2 and Secretin families, from which the acronym GRAFS is derived. The authors of GRAFS were able successfully to differentiate pseudogenes from functional genes, and were also able to classify all human GPCR and leading to the identification of several new GPCRs [42] [43] [44] [45] [46] [47] [48] [49] .
The GRAFS GPCR families arose before the chordate lineage diverged from the lineage leading to nematodes as the nematode Caenorhabditis elegans has more than 100 receptors belonging to the GRAFS GPCR families [50] . In parallel to the GRAFS families, other GPCR families have arisen and/or evolved in specific lineages or species, such as the plant MLO receptors [51] and the insect gustatory receptors [52] .
Likewsie, GPCRs in fungi, plants and animals have no sequence similarity, except for one Adhesion-like GPCR found in thale cress (Arabidopsis thaliana) [53] .
Thus, when looked at in isolation, or more typically from a purely anthropomorphic perspective, defining families that span and classify the GPCRs is more taxing than perhaps it should be. For example, the group typified by the vomeronasal type 1 receptors [54] , which are involved in pheromone recognition [55] , is large and its members numerous in all mammals studied, yet in humans these genes number only five. Other, less easily categorised outlier GPCRs also exist. They can and do prove problematic to both manual and automated classification systems.
Examples include the Ocular albinism receptor [56] , ITR [57] , and GPR108 [58] , which are all only present as a single copy in humans.
GPCR Repertoire
In spite of the high degree of structural similarity within the GPCR superfamily, the totality of the evidence presented above is consistent with the assertion that the discernible similarity across the whole tranche of proteins called or classified as
GPCRs is so low as to make a proper, unambiguous phylogenetic analysis of these proteins next to impossible. Thus the lack of overt sequence similarity between GPCR families makes a putative common origin very much an open question. An agnostic view is perhaps warranted, suggesting that most of the various classes described above originated independently during evolution. Of the classes, adhesion and secretin families are most likely to have originated together [59] . This ambiguity is by no means a unique phenomenon in biology. The lipocalin protein is another example [60] [61] [62] [63] [64] [65] [66] [67] [68] with many similar features. They too have a highly conserved structure yet their similarity is often so low as to have frustrated its detection.
However, it is still perfectly possible to audit the complement of GPCRs or other proteins within a genome or proteome, irrespective of any spurious or specious evolutionary rationale that one is obliged to impose by biologist's dogma. Various methods have been used to identify this so-called "repertoire" of GPCRs within the various genomes sequenced to date. Repertoires are, in a conceptual sense, genomes within genomes, or sub-genomes: the total number of a particular variety of protein or members of a protein family.
Previous best guesses put the number of GPCRs within the human genome at approximately one percent of total genes, with other estimations putting the number of GPCRs involved in olfaction at an inaccurate and unlikely additional 1000-2000.
These figures, and the more accurate numbers given below, should be set against the size of the human genome. Currently, the principal human genome sequence is a composite from five different individuals: its putative size has been whittled or winnowed down from figures in excess of 100,000 first to about 40000 genes and then to around 20,000. A recent and more reliable assessment from 2006 puts the number of coding genes at or about 25,043 [69] ; while, a 2007 estimate puts the value at about 20,488, with perhaps another 100 genes yet to be found [44] .
An early analysis by Fredriksson et al. [40] put the total number of human GPCR genes at 802, while Niimura and Nei have put the current number of olfactory receptor (OR) genes at 388 and pseudogenes at 414 [70] . Subsequently, Fredriksson and co-workers, and indeed several other groups as well, have been able to identify many new rhodopsin-like and adhesion-like GPCRs in the burgeoning suite of genomes available for study. In light of this the size of any genome and the number of GPCRs within it must remain educated guesses. While both will alter, particularly as the genomes of individual humans are sequenced, we can be reasonably confident that the majority genes and most GPCRs have been discovered.
The increasing refinement of the human genome assembly has allowed for more sophisticated in silico analysis to be undertaken. The Human Genome Project used a combination of protein families and protein domains to estimate that there are 616 GPCR sequences belonging to Classes A, B and C. A motif-based approach was used whereby InterPro estimated the total number of Rhodopsin-like GPCRs to be 569 [71] . Takeda and colleagues extracted approximately 950 open reading frames from the human genome that had 200-1500 amino acid residues similar to those of GPCRs [72] . The GPCR repertoires of several other species have also been published, including mouse [41] , rat [46] , chicken [45] , pufferfish [73] , amongst several others.
The recently-determined G protein-coupled receptor repertoire within the dog genome was shown to be more similar to that found in humans than that found in rodents [42] .
GPCR Training and Test Sets for Classification Algorithms.
In the machine learning scenario, a classification algorithm is trained with examples (i.e. GPCRs) with known classes and the classification model discovered from this set is used to predict the classes of further examples drawn from a separate test set, which were unseen during training. Issues of clarity, precision and bias are faced when we try to define the training and test sets to be used in GCPR classification. It is clearly worth ventilating some of the more apposite issues here.
Usually, one would expect verification through the use of independent test data to be ideal; however, things can be deceptive. In general, the choice of both training and testing examples is important. Predicting examples very similar to training data is typically much easier prospect than predicting instances which are wildly unalike.
Consider the classification task of predicting whether or not a protein is a GPCR. In this task the training set would contain, as positive examples, proteins known to be GPCR, whilst the negative examples would be proteins known not to be GPCRs. to an evaluation (and thus influences the choice of the test and the way that the test is conducted) it is never truly independent. It is well known that published comparative tests, as conducted by a particular experimenter, will typically favour their own work over that of others.
The above discussion considered the classification task of discriminating GPCRs from non-GPCRs. However, other types of classification problems can be defined for
GPCRs. In particular, one can have a training set where all examples are known to be GPCRs, and then try to predict to which class a given GPCR protein belongs. For example, when developing GPCR classification algorithms, Davies et al. [74] built as large and comprehensive a dataset of GPCR sequences as possible with which to train and test the classifier. All protein sequences for the dataset were obtained from Entrez [75] using text-based searching and these were used to construct each GPCR subfamily and Class level dataset. Only human proteins sequences were incorporated, with the exception of Class D proteins, which are found only in fungi, and Class E, which is only found in Dictyostelium. Atypically short, and probably incomplete, GPCR sequences less than 280 amino acids were removed, as were all duplicate sequences. Thus the construction of this data set, which relied on accumulated annotations extant within database, also relied on the insight, and the bias, of the many, many investigators who worked on the problem over the decades.
Sequence based approaches to the Annotation of GPCRs
A central dogma within bioinformatics, which provides a key justification and raison d'être for the discipline, is that there exists a strong and readily-discernible relationship between the sequence of a protein and its structure. This relationship provides a de facto link between sequence and function, as function arises largely from the dynamic 3-dimensional structure of a folded protein not from its sequence.
This implies that the function of a newly discovered protein can be determined, at least in part, by determining the similarity of its sequence to the sequence of a known and studied protein.
As we mentioned above, the virtual global proteome nears completion [1] . That is not to say that all sequences will have been determined but that within the next few years all truly distinct sequences are expected to be discovered. From then on, with rare exceptions or the discovery of novel forms of life, such perhaps as any organic component of nanobacteria, sequencing will move from a bold and exciting era of discovery to a more mundane era of cataloguing and correction. To make a fanciful if not wholly inappropriate allusion, we will move from the era of Magellan, Cook, and Amundsen, to the era of the global positioning system. The glamour and excitement then will move inexorably away from the low hanging fruit of genome sequencing and focus instead on the use of the information in productive ways. Analysis of the GPCRs is just one such endeavour.
We do know that GPCRs with the same ligands can and do bind different G proteins. We also know that GPCRs binding the same G protein can bind completely different ligands [76] [77] . Likewise, two GPCRs may bind the same ligand and bind the same G protein yet have less than 25% sequence identity. GPCRs for melanocortin, lysophosphatidic acid and sphingosine 1-phosphate have an atypically high degree of sequence similarity yet their functions are unrelated. Clearly, this is and may remain an on-going challenge; which is another way of saying that it is a difficult and complex problem demanding a solution. Fortunately, the importance of the GPCR as physiological agents and drug targets more than justifies our efforts to address and resolve this challenge.
Full-length Sequence Searching Approaches to the Discovery and Annotation of GPCRs.
Arguably, the most obvious and straightforward approach to characterising a protein sequence usually involves searching a sequence database -which contains within it sets of previously annotated sequences -using a pair-wise similarity tool, such as FastA [78] or BLAST (Basic Local Alignment Search Tool) [79] . BLAST searches typically reveal obvious similarities between the query and one or more sequences in the database, as determined from pair-wise alignments along with concomitant statistical significance. Proteins are listed, as ranked by expectation or 'E' values. Such values are a measure of the reliability of the similarity calculated by the method. Low E values are more significant, implying the greater reliability of the identified relatedness between the two sequences.
For a GPCR query, most proteins sitting at the top of the list, and thus evincing high sequence identity, will be true GPCRs. BLAST searches have often identified new GPCR proteins, mainly where there is detectable sequence similarity to other GPCR sequences, a situation which is becoming increasingly uncommon. Currently, this kind of obvious similarity is harder and harder to find, as bioinformaticians find themselves increasingly working at the margins.
In the present era, BLAST, while well-used, is often of limited value for hunting out new members of the GPCR superfamily, since there is often a low degree of sequence similarity between the six families and between outliers within groups. An ideal result will show unambiguous similarity to a well-characterised protein over the full length of the query. However, often outputs contain no significant hits.
Obviously, a more typical state of affairs would fall between such extremes, affording a list of incomplete matches to a wide variety of proteins. Many of these hits will be uncharacterised or have dubious or contradictory annotations [80] . The difficulty then lies in the reliable inference of homology (the verification of a divergent evolutionary relationship) and, from this, the extrapolation to biological function.
Why is this? As the size of sequence databases rises inexorably, and are increasingly contaminated by populations of poor-quality or partial sequences, the probability of making high-scoring yet actually random matches will also rise. their own strengths and weakness can achieve such an objective.
Motif-based approaches to the Discovery and Annotation of GPCRs.
To a first approximation, BLAST generates generic, full-length similarities between sequences, while so-called motif-based approaches focus on specific, lengthrestricted traits unique to families or sub-families. Many protein family databasesmost famously typified by PROSITE [86] or PFAM [87] , and latterly subsumed by
InterPro [88] , a system combining sequence profiles from several databases -are built on such an approach. They use multiple alignments to identify highly conserved regions that can form the basis of characteristic, and even diagnostic, motifs for family or subfamily membership.
Of available approaches -single motifs through to HMM models of entire sequences -perhaps the more informative are so-called "fingerprints". GPCR fingerprints have been developed using patterns of common conservation within the seven transmembrane regions [89] [90] [91] . Rather than identifying a single, lone motif, fingerprinting looks at many short yet conserved regions within the sequence group. Sub-family and sub-sub-family level fingerprints are derived from segments within the TM regions, parts of the loops and parts of the N-and C-termini. False positives are readily determined since typically sequences will lack one or more of the motifs.
The PRINTS database system [91] As we have stressed, an intrinsic limitation of any supervised learning algorithm in the classification scenario is that a classification model constructed from a training set can only have a chance of good predictive accuracy on a test set that is derived from the same (or at least similar) probability distribution as the training set. Predictive models should always be tested for accuracy before being used. A particularly suitable method of assessing a model's accuracy is by using cross-validation. This method splits the full data set into several -typically 10 -independent, nonoverlapping sets. The classification algorithm is executed many times. During each cycle, one of the partitions is kept back as the test set and the algorithm is trained on the remainder. Accuracy is assessed using the single partition that had been kept back previously. In this way, it can be hoped that test and training sets become as representative as possible.
The goal of all GPCR classification studies is to take a protein or genome sequence and classify it. To achieve this, predictive methods -speaking in generalities -are in want of three things: appropriate structural representations of the sequences being used to train them; an equivalent list of biological status (i.e. membership of superfamily, family, type, and subtype) corresponding to these sequences; and some form of computational engine capable of predicting relationships between the particular description of the sequences and their associated status. The outcome of this process is a predictive model relating structure to status (class). The induction engine can take any one of many different forms, such as machine learning or statistical pattern recognition techniques, as described here.
An example of Artificial Neural Networks (ANNs) in the analysis of GPCR data is the use of Self-Organising Maps (SOMs) [94] . SOMs perform unsupervised learning (in this case, clustering) to discriminate protein families from each other. Sequences from the same family are expected to form a cluster although it cannot be assumed that the clusters will be visually recognized on the SOM output map. The overall performance of the map can be assessed using the sensitivity and specificity values as well as calculating the total accuracy of the clustering. Otaki et al. [95] reported a 97.4% precision at clustering 12 Class A sub-families using SOMs.
A Hidden Markov model or HMM is a statistical model where the system being modelled is assumed to be a Markov process with unknown parameters. In a Markov process, the probability distribution describing future states depends solely on the present state not on states prior to that: the future depends upon the present not the past. In a regular Markov model, the state is seen by the observer and thus only state transition probabilities are parameters. In a HMM, the state is not visible, although variables influenced by that state can be seen, and so the aim is to determine the hidden parameters from the observable parameters. HMMs have gained significant currency, particularly when used for sequence alignment [96] .
Support Vector Machines (SVMs) are machine-learning algorithms based on statistical learning theory [97] . In two-class problems, an SVM maps two sets of distinct data representing sequence descriptions onto a multi-dimensional feature space and then sets about constructing a division between the classes. The optimal division is one with a maximum distance to the closest data point from each of the two classes. Finding this optimal division is important since should another data point be added, it is easier to classify it correctly when there is a significant separation between classes. The data points nearest to the optimal division are termed support vectors. Although SVMs are more commonly used to solve 2-class problems, this technique can been applied to GPCR classification with more than two classes by running the algorithm multiple times (i.e. once for each class) [98] .
Alignment Free Methods approaches to the Discovery and Annotation of GPCRs: Proteochemometrics, Properties, and Statistics
Rather than aligning sequences, and from such alignments deducing pseudoevolutionary relationships, alignment-independent classification systems use the physiochemical properties of amino acids to give insight into functionally or structurally important differences between sequences. To enable this process, we need to turn the symbolic structure of the protein into a set of numbers.
Proteochemometrics is an example of such an approach; it has been applied to the classification of the GPCR superfamily. 
CLASSIFYING GPCR HIERARCHICALLY
In the last decade or so, networks have emerged from relative obscurity to become a powerful, pervasive, perhaps even dominant, description of complex biological, chemical, and physical systems. Such networks are often organized as a hierarchy.
Networks arise in nature in many areas, and biology in particular is replete with examples: epidemiology, neural networks for locomotion, vision, speciation and the synchronous flashing of fireflies.
The standard depiction of a hierarchy represents it in the form of a tree or dendrogram. The word dendrogram comes from the Greek dendron meaning "tree"
and gramma meaning "drawing". Within such trees, collections of nodes are divided into groups; groups that split into a succession of sub-divisions, usually over several levels. Arguably, the most familiar and immediate dendrogram is to most of us a family tree. In a family tree, individuals are connected to their siblings through direct parental lineage, and are connected to their cousins through a shared lineage in prior generations: grandparents and great-grandparents, and so on.
Going beyond mere straightforward clustering, the hierarchical nature inherent within networks implies significant organization at many levels. Sub-groups within networks often correspond to well-understood functional units: modules in proteinprotein interaction (PPI) networks, metabolic networks, or genetic regulatory networks; communities in social networks; or ecological niches in food webs.
Hierarchies explain many general network properties, including their highly connected nature. The implication is that the hierarchy is a key organizing principle common to all complex networks, however they arise.
Traditionally, readily discernible groups within a network are deemed assortative or disassortative. In assortative networks, groups comprise members which are highly, and close to equally, interconnected, yet there are relatively fewer connections between groups. Disassortative networks are characterised by a few highly-connected hubs and many other nodes with very few connections. Compared to many other problems explored so thoroughly by computer science and computer scientists, hierarchical classification is a relatively under-investigated special case of the broader and rather better-known area labelled classification. Rather than trying to predict a set of classes without discernible and overt complex mutual dependency, classes are arranged in a furcating hierarchy of many levels [108] . In an informatic context, higher-level classes correspond to general functions, whilst lowerlevel classes correspond to more specific functions. Specific classes will inherit the features or functions of their parents. An important distinction, when doing hierarchical classification, is whether the class hierarchy has the structure of a tree or direct-acyclic-graph (DAG). In a "tree-structured class hierarchy" each class has just one "parent class", although a parent class can have many child classes. In a "DAG- There exist several strategies for predicting hierarchical classes [108] . The simplest is to flatten the dataset to the deepest (most specific) level of the hierarchy, then use one of many standard "non-heirarchical" classification algorithms to predict classes.
This strategy is wasteful: it fails to take full advantage of the information implicit within the class hierarchy and tends to obtain smaller predictive accuracy than truly hierarchical classification approaches, especially when the number of classes is large.
Very different is the global approach. This utilises a single, but complex, hierarchical classification algorithm that considers all hierarchical relationships among all classes in a single execution of the algorithm. Perhaps due to its complexity, implementations of such an approach are scarce, although one such model has been used for gene function prediction in Saccharomyces cerevisiae [109] .
A different hierarchical classification strategy is the so-called local method, nicknamed the top-down approach. In some sense, this represents an intermediate approach between the extremes of algorithmic simplicity and complexity associated with the flat and big-bang approaches. In the top-down approach, during training, a tree of local classifiers is constructed. This tree of local classifiers mirrors the distribution of classes in the class tree. In the testing phase, examples are classified by first exposing the unknown example to the classifier at the root node. A prediction is made and used to decide to which child (1st level) classifier the example will be transferred. This process continues until all examples have been categorised by the classifier at a leaf node. Usually, every node uses the same classification algorithm to formulate the local classifier at that node.
In light of the inherently hierarchical nature of networks -both networks constructed and observed by the human mind -we have attempted to make use of this powerful idea and constructed a means of using the concept of a hierarchy directly to help us automate the prediction of the many-levelled GPCR classification. Davies et al. [74] developed an alternative to this top-down hierarchical classification method by using a set of potential classification algorithms at each node, and selecting the best classifier at that stage. This 'selective top-down approach' has been found to outperform a standard top-down classifier in the GPCR classification task. However, the selective approach can be slow in training, particularly if the number of classes is large.
In the examples cited above, the data set contained 8354 protein sequences in 5
classes at the family level (A-E), 40 classes at the sub-family level and 108 classes at the sub-subfamily level. Class F was not considered as it contains too few sequences from which to develop an accurate classification algorithm. Moreover, rather than use the primary sequence to perform the classification, which would rule out the use of the vast majority of traditional classifiers, the system uses an alternative form of protein data representation. Their approach used a simplified version of the representation used in proteochemometrics, making use of Wold's five z-values.
Since data mining algorithms do not tend to work with variable numbers of descriptors, it proved necessary to normalize the z-values so that all proteins had the same number of variables. Davies et al. [74] used a normalization method which calculated the arithmetic mean for each z value over the whole protein. This very simple technique was found to retain predictive accuracy while significantly reducing requirements for storage and processing time.
Later, they made use of an augmented version of this attribute creation method. In this case, 15 attributes described each protein. Five were created as described above but in addition to this, five more were created from the N-terminus of the protein and five from the C-terminus. Therefore, in the case of the N-terminus, the means for each of the five z-values were computed for only the first 150 amino acids, while in the case of the C-terminus, the means over the last 150 amino acids were also determined.
The selective top-down approach was implemented in WEKA [6] : and made use of 10 classification techniques, namely: Naïve Bayes method, a Bayesian network, a SVM [110] , nearest neighbour, the PART rule induction algorithm, J48 (WEKA's implementation of the well-known C4.5 decision tree induction algorithm), a Naïve
Bayes tree, a multi-layer neural network with back propagation, an artificial immune system, and a conjunctive rule learner. Our approach exploits the idea that some characteristics may be important to distinguish protein subsets at one classification level while being relatively unimportant at another. Classifiers were chosen in a training data-driven manner. Since different classifiers may be more suited to certain nodes of the class hierarchy, it was assumed that the overall classification accuracy should increase if a diverse set of algorithms is used within the hierarchy.
Compared to the standard top-down approach with the same classifier at every node, this selective approach involves additional steps: at each node, training data is randomly assigned between sub-training and validation sets; several classifiers are then trained using this sub-training data set and tested using the validation data set.
The classifier with the greatest resulting classification accuracy is then selected for that particular node. Finally, the selected classifier is re-trained using the full original training data.
The headline accuracy statistics for the selective top-down approach were 95.87%
at the family level (5 classes), 80.77% at the sub-family level (38 classes), and 69.98% at the sub-subfamily level (87 classes). Overall, our approach out-performed all single-classifier methods, and also compared favourably with several extant servers using both our data sets and theirs.
Recently, this approach has also been extended in 2 ways. First, we used our adaptive approach to reduce the innate complexity involved in representing the 20 standard amino acids. There exists no universally-applicable reduced alphabet despite the numerous criteria upon which to group the amino acids. An optimization algorithm was developed to identify the most efficient grouping when classifying GPCRs [111] [112] .
Secondly, through the addition of an attribute selection step, where selection occurs independently at each node in a data-driven manner, leaving only those attributes that best discriminate classes at that node [113] . The number of attributes selected was highly variable between classifier nodes, but varied little for the same node during repeated cross-validation. Thus, it was postulated that the attribute selection method is reacting to the varying levels of difficulty of predicting particular classes at different positions in the class tree. It was found that the addition of this attribute selection stage made no significant difference to the predictive accuracy of the hierarchical classification system, yet did afford the advantage that the processing time was reduced significantly.
Prediction Servers
A question commonly articulated by those tasked with discovering and understanding biology, rather than those tasked with developing tools to analyse data, is this: what is the value of creating methods that cannot be used? Few have the time to implement all published methods that might prove useful, so it is that the prevalence of internet servers comes to resolve this dilemma. Many such servers are now available for the identification and classification of GPCRs. We adumbrate a few below.
HMMTOP (Hidden Markov Model for TOpology Prediction), available at URL:
http://www.enzim.hu/hmmtop/, uses the idea that TM regions have the most atypical amino acid composition [114] , and that such region may be determined by looking for maximum divergence rather than identifying regions with a specific composition.
Thus, the topology of membrane proteins can be determined if their amino acid sequences can be segmented into specific regions in such a way that the product of the relative frequencies of the amino acids of these segments along the amino acid sequence should be maximal. Given this unusual distribution within the training set, it seems unlikely that the classification model would prove highly predictive when applied to larger GPCR datasets with a less atypical class distribution.
GPCRsClass [118] , URL: http://www.imtech.res.in/raghava/gpcrsclass/, is a SVMbased server that focuses on Class A GPCRs. Using dipeptide composition, GPCRsClass is 99.7% accurate at dividing amine from non-GPCRs, and 92%
accurate when splitting sequences into sub-subfamilies. A similar program from the same stable, GPCRPred, URL: http://www.imtech.res.in/raghava/gpcrpred/, first determines if a sequence is a GPCR, then which class it belongs to, and finally, assuming it is a Class A GPCR, to which subfamily it belongs [119] . GPCR vs non-GPCR sequences had 99.5% accuracy, the Class prediction was 97.3% accurate, and the sub-family was on average 85% accurate.
The hierarchical approach to GPCR classification developed by Secker, Davies, and co-workers, and described at length above, has also been made available freely over the world wide web, implemented within the webserver GPCRTree [120] such servers can be used as a semi-independent check on the location of TM helices.
Discussion and Conclusion
Currently, molecular biology is generating prodigious quantities of genomic data, as a result of a number of automated experiments. It is tempting to conceive of the genome (the entire complement of genes comprising an organism) as an "encoded text" that is progressively decoded to produce proteins. But to decode this properly, that is in terms of function and interaction we need to leverage our knowledge in a dynamic and adaptive fashion. Knowledge is information that has been properly organised, integrating raw and visceral fact with complex, subtle, multi-levelled meaning.
Understanding is the deepest and most profound cognitive level available to us; where we would be able not just to catalogue bald observations, but gain true and pervasive insight into not just how something happens but why and in what way it happens. In other words, beyond knowledge is understanding, an almost intuitive grasp of the whys that enables us to manipulate and to manage the world of our existence, not just experience it. With the emergence of knowledge and understanding comes the ability to make intuitive predictions, to organize rationally, and to design and create; in short, to escape the limitations imposed by precedent and provenance, and remake the familiar world in the image of our aspirations.
However, it is, is it not always worth challenging our assumptions? Thus, at this stage, it might be appropriate to ask an important question: why is it important to address so well studied a superfamily as the GPCRs? There are several answers to this Having said all that, it must be remembered that the pharmaceutical industry has ceased to be the unstoppable engine of unalloyed, ever-increasing profitability that GPCRs. This includes 25% the top 100 drugs, many of which are so-called blockbusters, each earning over $1 billion dollars a year.
Available biological databanks are now remarkably numerous; indeed, they require a database of their own to catalogue them [125] , thus necessitating a significant degree of automated rather than manual data analysis. Manual analysis is, to lapse into the vernacular, slow but sure; automated analysis can be rapid yet uncertain.
Annotation or labels within sequence databases are often inferred from observed similarities to homologous, annotated proteins. This may create error, particularly when sequence similarity is marginal. As a result, it is widely believed that there are now substantial numbers of incorrect annotations throughout commonly-used databases [126] . Most orphan GPCRs have relatively low sequence similarity to well characterised GPCRs with known functions and/or known ligands; it is therefore often difficult to infer information about their function. It is possible that many of these orphan receptors have ligand-independent properties, specifically the regulation of ligandbinding GPCRs on the cell surface [128] [129] . This was first suggested when a study of the Class C metabotropic γ-aminobutyric acid B (GABA B ) receptor showed that it was a heterodimer composed of two subunits, B1 and B2 [130] . GABA B1 was responsible for the binding of the ligand while the GABA B2 subunit promotes the efficient transport of GABA B1 . It is also possible that many of the orphan receptors are also responsible for the regulation of non-orphan GPCR cell surface expression, in either a positive [131] or negative way [128] . If this is true then the relative expression of orphan and non-orphan GPCR proteins could be an important factor for the regulation of cell signalling. There has also been considerable interest in the tendency of GPCRs to form higher order oligomers in living cells [132] . Dimeric ligands linked by spacer arms have been used to identify the importance of coexpression of certain GPCR subtypes, indicating that the formation of these oligomers is a crucial part of GPCR signalling, although the extent to which oligomerisation occurs across the whole GPCR superfamily remains uncertain.
Speaking more generally, the search for novel GPCRs in a genome of interest, whatever it may be, is confounded by issues that arise from the complex nature of multi-gene families: database search techniques cannot easily differentiate between proteins that have arisen by a process of speciation (so-called orthologues, where the functional counterpart of a sequence is found in another species) and those that have arisen via intra-species duplication and divergence (so-called paralogues, which may perform related but distinct functions within the same organism).
Examination of the current literature shows that no real consensus exists for tackling the problem of in silico GPCR Classification. GPCR prediction is a complicated problem that may be beyond conventional bioinformatics techniques.
Classification models based upon motifs are both simple and comprehensible to the user, allowing the user to see why a GPCR has been assigned a particular classs, but have been observed to have false positive and false negative prediction rates that are do not allow the user to infer any information about the protein sequence other than to which family it likely belongs. Therefore there is arguably a trade-off between the accuracy of the predictive technique and the comprehensibility of its results [133] .
It should be noted that while many of the algorithms described show a high degree of accuracy, in most cases the technique has not been assessed independently. Further benchmarking of the techniques with several different GPCR datasets seems necessary. It may also be the case that a technique that is effective at determining
GPCRs from non-GPCRs would be less effective at the class, sub-family or sub-subfamily level. Different approaches could therefore be employed at each level of the classification. Furthermore, all the predictive techniques have hitherto been assessed using the GPCRDB Classification system. Future work in this field may need to be directed towards training algorithms based upon alternative classification systems, such as GRAFS, in order to determine the most comprehensive approach to classifying the GPCR superfamily.
Many commentators have questioned the long term viability of the so-called "blockbuster" drug, suggesting that the already fragmented pharmaceutical market is moving towards an era characterised by even more extensive fragmentation, where a plethora of individual, highly-focused markets are dominated not by a handful of big sellers but by a legion of niche products. Because of their well-characterised, easily druggable binding site, coupled to their vital biological roles, GPCRs remain the ultimate drug target. While we still need drugs, we will continue to explore the unique properties of the GPCR. This review has shown how we will take the next step on that road allowing us to more fully exploit as drug targets the as yet untapped potential of the entire GPCR family. A schematic dendrogram that illustrates the four level hierarchy that characterises the G Protein Coupled receptor (GPCR) umma, as used in our analysis [74] . Example of a hierarchical dataset (1) and how that hierarchy may be reflected in a tree of classifiers (2) 
